Health outcomes and economic burden of hospitalized COVID-19 patients in the United States (Unknown)
Free access
- New search for: Di Fusco, Manuela
- New search for: Shea, Kimberly M.
- New search for: Lin, Jay
- New search for: Nguyen, Jennifer L.
- New search for: Angulo, Frederick J.
- New search for: Benigno, Michael
- New search for: Malhotra, Deepa
- New search for: Emir, Birol
- New search for: Sung, Anita H.
- New search for: Hammond, Jennifer L.
- New search for: Stoychev, Sophia
- New search for: Charos, Apostolos
- New search for: Di Fusco, Manuela
- New search for: Shea, Kimberly M.
- New search for: Lin, Jay
- New search for: Nguyen, Jennifer L.
- New search for: Angulo, Frederick J.
- New search for: Benigno, Michael
- New search for: Malhotra, Deepa
- New search for: Emir, Birol
- New search for: Sung, Anita H.
- New search for: Hammond, Jennifer L.
- New search for: Stoychev, Sophia
- New search for: Charos, Apostolos
In:
Journal of Medical Economics
;
24
, 1
;
308-317
;
2021
- Article (Journal) / Electronic Resource
-
Title:Health outcomes and economic burden of hospitalized COVID-19 patients in the United States
-
Contributors:Di Fusco, Manuela ( author ) / Shea, Kimberly M. ( author ) / Lin, Jay ( author ) / Nguyen, Jennifer L. ( author ) / Angulo, Frederick J. ( author ) / Benigno, Michael ( author ) / Malhotra, Deepa ( author ) / Emir, Birol ( author ) / Sung, Anita H. ( author ) / Hammond, Jennifer L. ( author )
-
Published in:Journal of Medical Economics ; 24, 1 ; 308-317
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2021-01-01
-
Size:10 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Source:
Table of contents – Volume 24, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Healthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysisNiu, Xiaoli / Divino, Victoria / Sharma, Sanjay / Dekoven, Mitch / Anupindi, Vamshi Ruthwik / Dembek, Carole et al. | 2021
- 10
-
Healthcare resource utilization and costs for hip dislocation following primary total hip arthroplasty in the medicare populationMantel, Jack / Chitnis, Abhishek S. / Ruppenkamp, Jill / Holy, Chantal E. / Daccach, Juan et al. | 2021
- 19
-
A budget impact analysis of gilteritinib for the treatment of relapsed or refractory FLT3 mut+ acute myeloid leukemia in a US health planPandya, Bhavik J. / Yang, Hongbo / Schmeichel, Cynthia / Qi, Cynthia Z. / Shah, Manasee V. et al. | 2021
- 29
-
Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosisBloudek, Lisa M. / Gillard, Kristin Khalaf / Nguyen, Victor B. / Klein, Stephanie Zone et al. | 2021
- 38
-
Evaluation of access to care issues in patients with breast cancerBrown, Carolyn M. / Richards, Kristin M. / Vohra, Yogesh / Kanu, Chisom / Stevens, Laura / Sasane, Rahul / Balu, Sanjeev / McAneny, Barbara et al. | 2021
- 46
-
Identifying disability level in multiple sclerosis patients in a U.S.-based health plan claims databaseBerkovich, Regina / Fox, Edward / Okai, Annette / Ding, Yao / Gorritz, Magdaliz / Bartolome, Lauren / Wade, Rolin L. / Su, Wendy / Johnson, Kristen M. / Russo, Patricia et al. | 2021
- 54
-
Effect of direct oral feeding following minimally invasive esophagectomy on costs and quality of lifePattamatta, Madhuri / Fransen, Laura F. C. / Dolmans-Zwartjes, Annemarie C. P. / Nieuwenhuijzen, Grard A. P. / Evers, Silvia M. A. A. / Kouwenhoven, Ewout A. / van Det, Marc J. / Hiligsmann, Mickael / Luyer, Misha D. P. et al. | 2021
- 61
-
Economic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorderWang, Weijia / Gellings Lowe, Nicole / Jalali, Ali / Murphy, Sean M. et al. | 2021
- 69
-
The health economic impact of varying levels of adherence to colorectal screening on providers and payersHathway, Joanne M. / Miller-Wilson, Lesley-Ann / Yao, Weiyu / Jensen, Ivar S. / Weinstein, Milton C. / Parks, Philip D. et al. | 2021
- 79
-
A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancerRoth, Joshua A. / Yuan, Yong / Othus, Megan / Danese, Mark / Wagner, Samuel / Penrod, John R. / Ramsey, Scott D. et al. | 2021
- 87
-
Long-term cost-effectiveness of a disease management program for patients with atrial fibrillation compared to standard care – a multi-state survival model based on a randomized controlled trialGao, Lan / Scuffham, Paul / Ball, Jocasta / Stewart, Simon / Byrnes, Joshua et al. | 2021
- 96
-
Benefits of fracture liaison services (FLS) in four Latin American countries: Brazil, Mexico, Colombia, and ArgentinaAziziyeh, Rima / Perlaza, Javier Garcia / Saleem, Najma / Guiang, Hannah / Szafranski, Kirk / McTavish, Rebecca K. et al. | 2021
- 103
-
Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesiaGanz, Michael L. / Chavan, Ameya / Dhanda, Rahul / Serbin, Michael / Yonan, Charles et al. | 2021
- 114
-
Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in GermanySteinmetz, Tilman Hans / Singh, Moushmi / Lebioda, Andrea / Fink, Leah / Schoehl, Martina / Rieth, Achim / Gonzalez-McQuire, Sebastian / Engelhardt, Monika et al. | 2021
- 123
-
Estimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in AustraliaKotsopoulos, Nikolaos / Connolly, Mark P. / Li, Jinjing et al. | 2021
- 131
-
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United StatesCai, Beilei / Zhou, Zheng-Yi / Xue, Weiguang / Hazra, Nisha C. / Singh, Mukesh / Mishra, Dinesh / Brixner, Diana / Oderda, Gary / Biskupiak, Joseph et al. | 2021
- 140
-
Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progressionBrown, Laurie J. / Li, Jinjing / Brunner, Matthias / Snoke, Martin / La, Hai A. et al. | 2021
- 150
-
The cost-effectiveness of glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are not eligible to receive intensive induction chemotherapy in CanadaHu, Yannan / Charaan, Majed / van Oostrum, Ilse / Heeg, Bart / Bell, Timothy et al. | 2021
- 162
-
Willingness to pay for primary health care at public facilities in the Western Cape Province, Cape Town, South AfricaChiwire, P. / Evers, S. M. / Mahomed, H. / Hiligsmann, M. et al. | 2021
- 173
-
Comparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA studyHiguera, Lucas / Holbrook, Reece / Wherry, Kael / Rodriguez, Diego A. / Cuesta, Alejandro / Valencia, Juan / Arcos, Julián / López Gómez, Agustín et al. | 2021
- 181
-
Humanistic burden among caregivers of patients with Alzheimer’s disease or dementia in Japan: a large-scale cross-sectional surveyOhno, Shinya / Chen, Yirong / Sakamaki, Hiroyuki / Matsumaru, Naoki / Yoshino, Motoaki / Tsukamoto, Katsura et al. | 2021
- 193
-
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stageGagnon-Sanschagrin, Patrick / Liang, Yawen / Sanon, Myrlene / Oberdhan, Dorothee / Guérin, Annie / Cloutier, Martin et al. | 2021
- 202
-
Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United StatesVolk, Michael L. / Burne, Rebecca / Guérin, Annie / Shi, Sherry / Joseph, George J. / Heimanson, Zeev / Ahmad, Maliha et al. | 2021
- 212
-
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarinMilentijevic, Dejan / Lin, Jennifer H. / Chen, Yen-Wen / Kogan, Emily / Shrivastava, Shubham / Sjoeland, Erik / Alberts, Mark et al. | 2021
- 218
-
Budget impact analysis of Jivi (damoctocog alfa pegol, Bay 94-9027) in severe hemophilia A in JapanFujii, Teruhisa / Kidoguchi, Yuko / Takahashi, Noriko / Yu, Eric / Ainiwaer, Dilinuer / Byrne, Aidan et al. | 2021
- 226
-
Estimating the preferences and willingness-to-pay for colorectal cancer screening: an opportunity to incorporate the perspective of population at risk into policy development in ThailandPhisalprapa, Pochamana / Ngorsuraches, Surachat / Wanishayakorn, Tanatape / Kositamongkol, Chayanis / Supakankunti, Siripen / Chaiyakunapruk, Nathorn et al. | 2021
- 234
-
Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysisStein, Eytan M. / Bonifacio, Gaetano / Latrémouille-Viau, Dominick / Shi, Sherry / Guérin, Annie / Wu, Eric Q. / Sadek, Islam / Cao, Xiting et al. | 2021
- 244
-
Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysisHosogaya, Naoki / Takazono, Takahiro / Yokomasu, Akira / Hiroi, Shinzo / Ikeoka, Hidetoshi / Iwasaki, Kosuke / Takeshima, Tomomi / Mukae, Hiroshi et al. | 2021
- 255
-
Incidence, predictors, and economic burden of circular anastomotic complications in left-sided colorectal reconstructions involving manual circular staplersFortin, Stephen P. / Johnston, Stephen S. / Chaudhuri, Rusha / Fryrear, RaymondII / Roy, Sanjoy et al. | 2021
- 266
-
Burden of caring for Alzheimer’s disease or dementia patients in Japan, the US, and EU: results from the National Health and Wellness Survey: a cross-sectional surveyOhno, Shinya / Chen, Yirong / Sakamaki, Hiroyuki / Matsumaru, Naoki / Yoshino, Motoaki / Tsukamoto, Katsura et al. | 2021
- 279
-
Cost-effectiveness of tofacitinib compared with infliximab, adalimumab, golimumab, vedolizumab and ustekinumab for the treatment of moderate to severe ulcerative colitis in GermanySardesai, Aditya / Dignass, Axel / Quon, Peter / Milev, Sandra / Cappelleri, Joseph C. / Kisser, Agnes / Modesto, Irene / Sharma, Puza P. et al. | 2021
- 291
-
Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspectiveEngel Ayer Botrel, Tobias / Datz Abadi, Márcia / Chabrol Haas, Laura / da Veiga, Cássia Rita Pereira / de Vasconcelos Ferreira, Dominihemberg / Jardim, Denis Leonardo et al. | 2021
- 299
-
Risk and cost of infection-related hospitalizations in medicare beneficiaries with comorbid rheumatoid arthritis treated with abatacept versus other targeted disease-modifying anti-rheumatic drugsPatel, Vardhaman / Pulungan, Zulkarnain / Shah, Anne / Kambhampati, Mahesh / Lobo, Francis / Petrilla, Allison et al. | 2021
- 308
-
Health outcomes and economic burden of hospitalized COVID-19 patients in the United StatesDi Fusco, Manuela / Shea, Kimberly M. / Lin, Jay / Nguyen, Jennifer L. / Angulo, Frederick J. / Benigno, Michael / Malhotra, Deepa / Emir, Birol / Sung, Anita H. / Hammond, Jennifer L. et al. | 2021
- 318
-
Modeling the economic value of Ceribell Rapid Response EEG in the inpatient hospital settingNey, John P. / Gururangan, Kapil / Parvizi, Josef et al. | 2021
- 328
-
Real-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the USKong, Amanda M. / Pavilack, Melissa / Huo, Hairong / Shenolikar, Rahul / Moynihan, Meghan / Marchlewicz, Elizabeth H. / Chebili-Larson, Christina / Min, Stella / Subramaniam, Deepa S. et al. | 2021
- 339
-
Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in ChinaGuan, Xin / Li, Hongchao / Xiong, Xiaomo / Peng, Cike / Wang, Ning / Ma, Xiao / Ma, Aixia et al. | 2021
- 345
-
Influence of neurovascular embolic coil primary wind diameter on aneurysm packing density and case costsGrandhi, Ramesh / Kottenmeier, Emilie / Cameron, Heather L. / Kane, Sarah T. / Taussky, Philipp et al. | 2021
- 352
-
Healthcare resource utilization, costs and treatment patterns in patients with bipolar disorder treated with lurasidone or cariprazineHuang, Huan / Schmerold, Luke / Dembek, Carole / Fan, Qi / Dieyi, Christopher / Williams, G. Rhys / Loebel, Antony et al. | 2021
- 363
-
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic modelLi, Nanxin / Sawyer, Eileen K. / Maruszczyk, Konrad / Guzauskas, Greg / Slomka, Marta T. / Burke, Tom / Martin, Antony P. / O’Hara, Jamie / Stevenson, Matt / Recht, Michael et al. | 2021
- 373
-
A pragmatic methodology for the evaluation of digital care management in the context of multimorbidityLindemer, Emily / Jouni, Mohammad / Nikolaev, Nikolay / Reidy, Pat / Mattie, Heather / Rogers, Jameson K. / Giangreco, LouAnne / Sherman, Michael / Bartels, Matthew / Panch, Trishan et al. | 2021
- 386
-
Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costsWallick, Chris / Wu, Ning / To, Tu My / Keebler, Daniel / Moawad, Dalia et al. | 2021
- 394
-
Standard table direct anterior approach within an early discharge protocol for cementless total hip arthroplasty: experience from a Japanese hospitalNakakita, Yoshiatsu / Bourcet, Anh / Mantel, Jack / Park, HyeJin / Rossi, Anne / Oinuma, Kazuhiro / Shiratsuchi, Hideaki et al. | 2021
- 402
-
Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularizationDesai, Urvi / Kharat, Akshay / Hess, Connie N. / Milentijevic, Dejan / Laliberté, François / Zuckerman, Peter / Benson, John / Lefebvre, Patrick / Hiatt, William R. / Bonaca, Marc P. et al. | 2021
- 410
-
Corneal cross-linking versus conventional management for keratoconus: a lifetime economic modelLindstrom, Richard L. / Berdahl, John P. / Donnenfeld, Eric D. / Thompson, Vance / Kratochvil, David / Wong, Chiang / Falvey, Heather / Lytle, Grace / Botteman, Marc F. / Carter, John A. et al. | 2021
- 421
-
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United StatesSimons, Claire L. / Malone, Daniel / Wang, Michael / Maglinte, Gregory A. / Inocencio, Tim / Wade, Sally W. / Bennison, Craig / Shah, Bijal et al. | 2021
- 432
-
Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of careRibeiro-Oliveira, AntonioJr / Brook, Richard A. / Munoz, Kathryn A. / Beren, Ian A. / Whalen, John D. / Kleinman, Nathan L. / Yuen, Kevin C. J. et al. | 2021
- 440
-
The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database studyHepp, Zsolt / Lage, Maureen J. / Espaillat, Ramon / Gossain, Ved V. et al. | 2021
- 447
-
The cost-effectiveness of dacomitinib in first-line treatment of advanced/metastatic epidermal growth factor receptor mutation-positive non-small-cell lung cancer (EGFRm NSCLC) in SwedenNilsson, Fredrik O. L. / Gal, Peter / Houisse, Ivan / Ivanova, Jasmina I. / Asanin, Sandra T. et al. | 2021
- 458
-
Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United StatesLiu, Rongzhe / Oluwole, Olalekan O. / Diakite, Ibrahim / Botteman, Marc F. / Snider, Julia Thornton / Locke, Frederick L. et al. | 2021
- 469
-
Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United StatesYang, Xiaoqin / Laliberté, François / Germain, Guillaume / Raut, Monika / Duh, Mei Sheng / Sen, Shuvayu S. / Lejeune, Dominique / Desai, Kaushal / Armand, Philippe et al. | 2021
- 479
-
The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosisHersh, Carrie M. / Brook, Richard A. / Beren, Ian A. / Rohrbacker, Nicholas J. / Lebson, Lori / Henke, Christian / Phillips, Amy L. et al. | 2021
- 487
-
Budget impact analysis: can we afford the added value?Petrou, Panagiotis et al. | 2021
- 490
-
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in GermanyCai, Rui / Gerlier, Laetitia / Eichner, Martin / Schwehm, Markus / Rajaram, Sankarasubramanian / Mould-Quevedo, Joaquin / Lamotte, Mark et al. | 2021
- 502
-
Setting and maintaining standards for patient-reported outcome measures: can we rely on the COSMIN checklists?McKenna, Stephen P. / Heaney, Alice et al. | 2021
- 512
-
Novel acute therapies in the treatment of migraine: impact of re-dosing on cost–utility outcomesJohnston, Karissa M. / L'italien, Gilbert / Harris, Linda / Deighton, Alison / Popoff, Evan / Croop, Robert / Coric, Vladimir et al. | 2021
- 514
-
Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United StatesIannitti, David A. / Kim, Chong / Ito, Diane / Epstein, Josh et al. | 2021
- 524
-
A device category economic model of electrosurgery technologies across procedure types: a U.S. hospital budget impact analysisFerko, Nicole / Wright, George W. J. / Syed, Imran / Naoumtchik, Elena / Tommaselli, Giovanni A. / Gangoli, Gaurav et al. | 2021
- 536
-
Is there a correlation between total fertility rate, utilization of assisted reproduction technology, and national wealth in Europe?Lass, Amir / Lass, Geffen et al. | 2021
- 540
-
Real-world assessment of “OFF” episode–related healthcare resource utilization among patients with Parkinson’s disease in the United StatesThach, Andrew / Jones, Eddie / Pappert, Eric / Pike, James / Wright, Jack / Gillespie, Alexander et al. | 2021
- 550
-
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US populationBerger, Jeffrey S. / Laliberté, François / Kharat, Akshay / Lejeune, Dominique / Moore, Kenneth Todd / Jung, Young / Lefebvre, Patrick / Ashton, Veronica et al. | 2021
- 563
-
Cost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson’s disease patients treated with levodopa/carbidopaHansen, Ryan N. / Suh, Kangho / Serbin, Michael / Yonan, Chuck / Sullivan, Sean D. et al. | 2021
- 570
-
Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trialMagnuson, Elizabeth A. / Li, Haiyan / Vilain, Katherine / Armstrong, Ehrin J. / Secemsky, Eric A. / Giannopoulos, Stefanos / Adams, George L. / Mustapha, Jihad / Cohen, David J. et al. | 2021
- 581
-
Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims databaseExuzides, Alex / Wu, Ning / Sheinson, Daniel / Flores Avile, Carlos / Costantino, Cristina / Sidiropoulos, Paris et al. | 2021
- 589
-
Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressantsPark, HyeJin / Park, Chan Mi / Woo, Jong-Min / Shin, Ju-Young / Lee, Eui-Kyung / Kwon, Sun-Hong et al. | 2021
- 598
-
Conversion from pegfilgrastim with on-body injector to pegfilgrastim-jmdb: cost-efficiency analysis and budget-neutral expanded access to prophylaxis and treatmentMcBride, Ali / MacDonald, Karen / Fuentes-Alburo, Adolfo / Abraham, Ivo et al. | 2021
- 607
-
Cost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden: an update with 5-year dataChaudhary, Mohammad A. / Holmberg, Christoffer / Lakhdari, Khalid / Smare, Caitlin / Theriou, Chloi / Dale, Peter / Penrod, John R. et al. | 2021
- 620
-
Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival statusHart, Allyson / Ahn, Yoon Son / Watson, Crystal / Skeans, Melissa / Barlev, Arie / Thompson, Bryn / Dharnidharka, Vikas R. et al. | 2021
- 628
-
Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in SpainCarcedo Rodriguez, David / Artola Urain, Teresa / Chinea Rodriguez, Anabelle / García Torres, Estefanía / González Vicent, Marta / Gutiérrez García, Gonzalo / Regueiro García, Alexandra / Calvo Hidalgo, Marcos / Villacampa, Alba et al. | 2021
- 637
-
Cost-effectiveness and budget impact analyses of tisagenlecleucel in adult patients with relapsed or refractory diffuse large B-cell lymphoma from Singapore’s private insurance payer’s perspectiveWang, Xiao Jun / Wang, Yi-Ho / Li, Shing Chau Tony / Gkitzia, Christina / Lim, Soon Thye / Koh, Liang Piu / Lim, Francesca Lorraine Wei Inng / Hwang, William Ying Khee et al. | 2021
- 654
-
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare populationFisher, Deborah A. / Karlitz, Jordan J. / Jeyakumar, Sushanth / Smith, Nathaniel / Limburg, Paul / Lieberman, David / Fendrick, A. Mark et al. | 2021
- 665
-
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world dataYang, Jingyan / Liu, Rongzhe / Granghaud, Anna / Zaidi, Omer / Stephens, Jennifer et al. | 2021
- 675
-
Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancerThurgar, Elizabeth / Gouldson, Mark / Matthijsse, Suzette / Amonkar, Mayur / Marinello, Patricia / Upadhyay, Navneet / Nwankwo, Chizoba / Aguiar-Ibáñez, Raquel et al. | 2021
- 689
-
Continuity and change in the drug supply chain: actors, actions, and aversionsMendoza, Roger Lee et al. | 2021
- 698
-
Quality outcomes, healthcare resource utilization and costs in Medicare patients with chronic heart failure with reduced ejection fraction with and without a worsening eventMentz, Robert J. / Pulungan, Zulkarnain / Kim, Seung / Yang, Mei / Teigland, Christie / Hilkert, Robert / Djatche, Laurence M. et al. | 2021
- 706
-
Burden of illness among Medicare and non-Medicare US populations with acquired thrombotic thrombocytopenic purpuraPollissard, Laurence / Shah, Anne / Punekar, Rajeshwari S. / Petrilla, Allison / Pham, Huy P. et al. | 2021
- 717
-
Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice surveyMartelletti, Paolo / Schwedt, Todd J. / Vo, Pamela / Ritrovato, Daniela / Reilly, Margaret C. / Naclerio, Mariantonietta / Ranjan, Pallavi / Kleebach, Joern / Joshi, Parth et al. | 2021
- 727
-
Cost-effectiveness of defibrotide for treatment of severe veno-occlusive disease: it is time for evidence based economic evaluationsGratwohl, Alois et al. | 2021
- 730
-
Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)Rosli, Mohd Rozaini / Wu, David Bin-Chia / Neoh, Chin Fen / Karuppannan, Mahmathi et al. | 2021
- 741
-
The tyranny of the SW quadrantPetrou, Panagiotis et al. | 2021
- 743
-
Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancerMcBride, Ali / MacDonald, Karen / Fuentes-Alburo, Adolfo / Abraham, Ivo et al. | 2021
- 757
-
Criteria for oral appliance and/or supine avoidance therapy selection based on outcome optimization and cost-effectivenessLevendowski, Daniel J. / Olmstead, Richard / Sall, Edward / Westbrook, Philip R. / Beine, Bretton / Munafo, Dominic et al. | 2021
- 764
-
Modelling the value of innovative treatments for Alzheimer’s disease in the United StatesMakin, Charles / Neumann, Peter / Peschin, Sue / Goldman, Dana et al. | 2021
- 770
-
Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in SwedenAcosta, Carlos / Gianinazzi, Mattia / Dort, Thibaut / Armstrong, Nigel / Ryder, Steve / Lundqvist, Thomas / Ekelund, Mats / Lycke, Jan et al. | 2021
- 781
-
Correction| 2021
- 782
-
Dose escalation and associated costs in biologic treatment of psoriasis based on real-world dataBagel, Jerry / Glick, Brad / Wu, Jashin J. / Chopra, Ishveen / Song, Xue / Brouillette, Matthew / Mendelsohn, Alan / Rozzo, Stephen / Han, George et al. | 2021
- 792
-
Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US – updated analyses with additional trial follow-upInsinga, Ralph P. / Feliciano, Josephine L. / Qiao, Nan / Vandormael, Kristel / Zhang, Ying et al. | 2021
- 806
-
Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitorsBurne, Rebecca / Balu, Sanjeev / Guérin, Annie / Bungay, Rebecca / Sin, Roxana / Paul, Mary Lisha et al. | 2021
- 816
-
Budget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United StatesStargardter, Matthew / McBride, Ali / Tosh, Jon / Sachdev, Rameet / Yang, Mo / Ambavane, Apoorva / Mittal, Madhav / Vioix, Helene / Liu, Frank Xiaoqing et al. | 2021
- 828
-
The impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countriesFinkelstein, Eric Andrew / Malkin, Jesse D. / Baid, Drishti / Alqunaibet, Ada / Mahdi, Khaled / Al-Thani, Mohammed Bin Hamad / Abdulla Bin Belaila, Buthaina / Al Nawakhtha, Ebrahim / Alqahtani, Saleh / El-Saharty, Sameh et al. | 2021
- 835
-
Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113Xue, Weiguang / Ribalov, Rinat / Zhou, Zheng-Yi / Ayyagari, Rajeev / Leo, Sam et al. | 2021
- 837
-
The improved survival rate and cost-effectiveness of a 7-day continuous subcutaneous insulin infusion setKwa, Timothy / Zhang, Gina / Shepard, Katie / Wherry, Kael / Chattaraj, Sarnath et al. | 2021
- 846
-
The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best–worst scaling approachWranik, Wiesława Dominika / Székely, Ronaldo-Raul / Mayer, Susanne / Hiligsmann, Mickaël / Cheung, Kei Long et al. | 2021
- 857
-
Reply to the concerns raised by McKenna and Heaney about COSMINMokkink, Lidwine B. / Terwee, Caroline B. / de Vet, Henrica C. W / Bouter, Lex M. / Alonso, Jordi / Patrick, D. et al. | 2021
- 860
-
COSMIN reviews: the need to consider measurement theory, modern measurement and a prospective rather than retrospective approach to evaluating patient-based measuresMcKenna, Stephen P. / Heaney, Alice et al. | 2021
- 862
-
Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697Kiri, Victor / MacKenzie, Gilbert et al. | 2021
- 864
-
Reply: Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697Harris, Linda / Graham, Sophie / MacLachlan, Sharon / Exuzides, Alex / Jacob, Saiju et al. | 2021
- 866
-
Healthcare costs of patients with cancer stratified by Khorana score risk levelsKhorana, Alok A. / Kuderer, Nicole M. / McCrae, Keith / Milentijevic, Dejan / Germain, Guillaume / Laliberté, François / MacKnight, Sean D. / Lefebvre, Patrick / Lyman, Gary H. / Streiff, Michael B. et al. | 2021
- 874
-
Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in SpainGonzález-Barcala, Francisco Javier / Muñoz-Gall, Xavier / Mariscal, Esther / García, Andrea / Yang, Shibing / van de Wetering, Gijs / Izquierdo-Alonso, José Luis et al. | 2021
- 883
-
Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UKRoze, Stéphane / Buompensiere, Maria Ida / Ozdemir, Zeynep / de Portu, Simona / Cohen, Ohad et al. | 2021
- 891
-
In Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113Serbin, Michael / Yonan, Charles / Ganz, Michael L. et al. | 2021
- 893
-
Reassessing the cost-effectiveness of nivolumab for the treatment of renal cell carcinoma based on mature survival data, updated safety and lower comparator priceKim, Hansoo / Goodall, Stephen / Liew, Danny et al. | 2021
- 900
-
Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and SpainVo, Pamela / Swallow, Elyse / Wu, Eric / Zichlin, Miriam L. / Katcher, Noah / Maier-Peuschel, Monika / Naclerio, Mariantonietta / Ritrovato, Daniela / Tiwari, Santosh / Joshi, Parth et al. | 2021
- 908
-
Continuing trends in U.S. brand-name and generic drug competitionGrabowski, Henry / Long, Genia / Mortimer, Richard / Bilginsoy, Mehmet et al. | 2021
- 918
-
Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlistDennen, Syvart / Díaz Espinosa, Oliver / Birch, Kelly / Cai, Jennifer / Sung, Jennifer C. / Machado, Paula G. P. / Shafrin, Jason et al. | 2021
- 930
-
Health care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancerHess, Lisa M. / Zhu, Yajun Emily / Fang, Yun / Liepa, Astra M. et al. | 2021
- 939
-
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASDMehta, Darshan / Davis, Matthew / Epstein, Andrew J. / Wensel, Brian / Grinnell, Todd / Thach, Andrew / Williams, G. Rhys et al. | 2021
- 949
-
Comparative efficacy, safety, and cost-effectiveness of abobotulinumtoxinA and onabotulinumtoxinA in children with upper limb spasticity: a systematic literature review, indirect treatment comparison, and economic evaluationDanchenko, N. / Johnston, K. M. / Haeussler, K. / Whalen, J. et al. | 2021
- 962
-
Economic burden of congenital athymia in the United States for patients receiving supportive care during the first 3 years of lifeCollins, Cathleen / Kim-Chang, Julie J. / Hsieh, Elena / Silber, Abigail / O’Hara, Matthew / Kulke, Sarah / Cooper, Megan A. et al. | 2021
- 972
-
Payer budget impact of an artificial intelligence in vitro diagnostic to modify diabetic kidney disease progressionDatar, Manasi / Burchenal, William / Donovan, Michael J. / Coca, Steven G. / Wang, Elaine / Goss, Thomas F. et al. | 2021
- 983
-
The burden of skeletal-related events in four Latin American countries: Argentina, Brazil, Colombia, and MexicoGarcia Perlaza, Javier / Aziziyeh, Rima / Zhou, Anna / De Sousa Barbosa, Vitor / Amaya, Jenny / Caporale, Joaquin / Alva, Monica Elena / Forero, Juan / Tanaka, Straus / Suri, Gaurav et al. | 2021
- 993
-
Impact of liposomal bupivacaine and provider choice on opioid use and service outcomes in Medicare outpatient surgical patientsDobson, Allen / Hartzman, Alex / Surfield, Christopher / DaVanzo, Joan E. et al. | 2021
- 1002
-
Cost of microvascular complications in people with diabetes from a public healthcare perspective: a retrospective database study in BrazilJulian, Guilherme Silva / Accetturi Pititto, Lilian Mariana / Miresashvili, Nino / Broe Honoré, Julie / Lopes Assis Coelho, Raquel Cristina / Campos, Daniel et al. | 2021
- 1011
-
Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the USHart, Allyson / Zaun, David / Itzler, Robbin / Schladt, David / Israni, Ajay / Kasiske, Bertram et al. | 2021
- 1018
-
Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessmentGoel, Nicholas J. / Bird, Cylaina E. / Hicks, William H. / Abdullah, Kalil G. et al. | 2021
- 1025
-
Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patientsDesai, Nihar R. / Alvarez, Paula J. / Golestaneh, Ladan / Woods, Steven D. / Coca, Steven G. / Rowan, Christopher G. et al. | 2021
- 1037
-
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in EnglandRaspin, Christopher / Shankar, Rohit / Barion, Francesca / Pollit, Vicki / Murphy, Joanna / Sawyer, Laura / Danielson, Vanessa et al. | 2021
- 1052
-
Cost of hemophilia A in Turkey: an economic disease burden analysisMalhan, Simten / Öksüz, Ergün / Antmen, Bülent / Ar, Muhlis Cem / Balkan, Can / Kavaklı, Kaan et al. | 2021
- 1060
-
Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysisPadula, William V. / Malaviya, Shreena / Reid, Natalie M. / Cohen, Benjamin G. / Chingcuanco, Francine / Ballreich, Jeromie / Tierce, Jonothan / Alexander, G. Caleb et al. | 2021
- 1070
-
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF modelSussman, Matthew / Di Fusco, Manuela / Tao, Charles Y. / Guo, Jennifer D. / Gillespie, John A. / Ferri, Mauricio / Adair, Nicholas / Cato, Matthew S. / Shirkhorshidian, Ilnaz / Barnes, Geoffrey D. et al. | 2021
- 1083
-
Comprehensive value assessments for new pediatric pneumococcal conjugate vaccinesHu, Tianyan / Weiss, Thomas / Bencina, Goran / Owusu-Edusei, Kwame / Petigara, Tanaz et al. | 2021
- 1087
-
Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims dataKorobelnik, Jean-François / Delcourt, Cécile / Creuzot-Garcher, Catherine / Melaine, Asma / Chassetuillier, Jules / Lejeune, Anne / Bénard, Stève / Dupont-Benjamin, Laure et al. | 2021
- 1098
-
Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countriesHu, Tianyan / Weiss, Thomas / Bencina, Goran / Owusu-Edusei, Kwame / Petigara, Tanaz et al. | 2021
- 1109
-
Determinants of market prices for drugs under Japan’s national health insuranceMamiya, Hiroaki / Igarashi, Ataru et al. | 2021
- 1115
-
Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United StatesJain, Sneha S. / Li, Sophia S. / Xie, Jipan / Sutton, Megan B. / Fine, Jennifer T. / Edelberg, Jay M. / Gao, Wei / Spertus, John A. / Cohen, David J. et al. | 2021
- 1124
-
Cost-effectiveness of nivolumab monotherapy in the third-line treatment of small cell lung cancerSmare, Caitlin / Dave, Kiran / Juarez-Garcia, Ariadna / Abraham, Pranav / Penrod, John R. / Camidge, D. Ross / Yuan, Yong et al. | 2021
- 1134
-
Modeling the optimal sequence of biologic therapies in plaque psoriasis in SpainEgeberg, Alexander / Danø, Anne / Pedersen, Mikkel H. / Sohrt, Anne / Borg, Emma / Notario, Jaime et al. | 2021
- 1143
-
Variation in access to hemophilia A treatments in the United StatesMargaretos, Nikoletta M. / Patel, Anisha M. / Panzer, Ari D. / Lai, Rachel C. / Whiteley, Jennifer / Chambers, James D. et al. | 2021
- 1149
-
Budget impact of optimizing rifaximin-α use for the prevention of recurrent hepatic encephalopathy in The Netherlandsde Jong, Lisa Aniek / van Schoonhoven, Alexander Victor / Hofstra, Hinko Stephan / Postma, Maarten Jacobus / van Hoek, Bart et al. | 2021
- 1164
-
Cost-minimization analysis of biweekly dosing of cetuximab and FOLFIRI compared with panitumumab and FOLFOX for first-line treatment of patients with KRAS wild-type metastatic colorectal cancer in the United StatesGathirua-Mwangi, Wambui Grace / Sethi, Harsheen / Afable, Manuel Geroy / Bhattacharyya, Devarshi / Khan, Taha et al. | 2021
- 1173
-
Patient out-of-pocket costs for suspicious pulmonary nodule biopsy in lung cancer patientsZheng, Feibi / Lavin, James / Sprafka, J. Michael et al. | 2021
- 1178
-
Cost analysis of the impact of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura from a US hospital perspectivePollissard, Laurence / Leinwand, Brian I. / Fournier, Marie / Pham, Huy P. et al. | 2021
- 1185
-
Number needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancerPaladini, Luciano / da Veiga, Cássia Rita Pereira / Cerqueira, Érica / Chabrol Haas, Laura / Datz Abadi, Márcia / Baldotto, Clarissa Seródio et al. | 2021
- 1194
-
Economic burden to commercial payers of young adults with schizophrenia in ColoradoPesa, Jacqueline / Patel, Charmi / Rotter, David / Papademetriou, Eros / Potluri, Ravi / Benson, Carmela et al. | 2021
- 1204
-
Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured populationPriest, Julie / Bhak, Rachel H. / Dersarkissian, Maral / Oglesby, Alan / Kunzweiler, Colin / Fuqua, Ellie / Park, Suna / Duh, Mei Sheng / Garris, Cindy et al. | 2021
- 1212
-
Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database studyKadakia, Aditi / Dembek, Carole / Liu, Yi / Dieyi, Christopher / Williams, G. Rhys et al. | 2021
- 1221
-
Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States populationShah, Ruchit / Corman, Shelby / Shah, Anuj / Kebede, Nehemiah / Nwankwo, Chizoba et al. | 2021
- 1231
-
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the NetherlandsSpoorendonk, J. A. / Briere, J.-B. / Bowrin, K. / Millier, A. / Coppens, M. / Tempelaar, S. / Verheggen, B. et al. | 2021
- 1240
-
Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysisHerrero, Jose Antonio / Salomone, Mario / Ramirez de Arellano, Antonio / Schaufler, Thilo / Walpen, Sebastian et al. | 2021
- 1248
-
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2Di Fusco, Manuela / Moran, Mary M. / Cane, Alejandro / Curcio, Daniel / Khan, Farid / Malhotra, Deepa / Surinach, Andy / Miles, Amanda / Swerdlow, David / McLaughlin, John M. et al. | 2021
- 1261
-
Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and WalesMattock, Richard / Gibbons, Ilana / Moss, Joe / Mealing, Stuart / Largeron, Nathalie / Carroll, Stuart / Alvarez, Fabián P. et al. | 2021
- 1272
-
Identifying chronic disease patients using predictive algorithms in pharmacy administrative claims: an application in rheumatoid arthritisMaksabedian Hernandez, Ervant J. / Tingzon, Isabelle / Ampil, Lorenzo / Tiu, Jessica et al. | 2021
- 1280
-
Evaluating the burden of pruritus due to atopic dermatitis in Japan by patient-reported outcomesMurota, Hiroyuki / Koike, Yuta / Ishii, Kanako / Calimlim, Brian M. / Ludwikowska, Maja / Toumi, Mondher / Kawaguchi, Isao et al. | 2021
- 1290
-
Respiratory morbidity, healthcare resource use, and cost burden associated with extremely preterm birth in The NetherlandsHouben, Eline / Siffel, Csaba / Overbeek, Jetty / Penning-van Beest, Fernie / Niklas, Victoria / Sarda, Sujata P. et al. | 2021
- 1299
-
Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapyPilon, Dominic / Karkare, Swapna / Zhdanava, Maryia / Sheehan, John J. / Côté-Sergent, Aurélie / Shah, Aditi / Lopena, Oliver J. / Lefebvre, Patrick / Joshi, Kruti / Citrome, Leslie et al. | 2021
- 1309
-
Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancerCarlson, Josh J. / Guzauskas, Gregory F. / Dann, Robert A. / Ramsey, Scott D. et al. | 2021
- 1318
-
Hospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trialTarride, Jean-Eric / Husain, Mansoor / Andersen, Andreas / Gundgaard, Jens / Luckevich, Maria / Mark, Thomas / Wagner, Lily / Pieber, Thomas R. et al. | 2021
- 1327
-
Healthcare utilization and cost burden of Huntington’s disease among Medicare beneficiaries in the United StatesExuzides, Alex / Reddy, Sheila R. / Chang, Eunice / Ta, Jamie T. / Patel, Anisha M. / Paydar, Caleb / Yohrling, George J. et al. | 2021
- 1337
-
Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumorsTawfik, Bernard / Ray, David / Moynihan, Meghan / Princic, Nicole et al. | 2021